Medtech Connect Episode 1: How Do We Regulate Software As A Medical Device?
Executive Summary
In the first episode of new podcast series Medtech Connect, Medtech Insight regulatory reporter Hannah Daniel interviews Foley and Lardner partner Kyle Faget about the complexities behind regulating software as a medical device (SaMD). Many companies are unsure if their software is even regulated by the FDA, let alone how to go about the clearance process. From managing cybersecurity risks to navigating digital health policy, Faget does it all, and she gives us insight into the regulatory landscape of SaMD in this month’s episode.
You may also be interested in...
What Can Tech Companies Teach Us About Clinical Trials?
Collaboration between tech companies and medical researchers may be the answer to modernizing clinical trials.
It’s Been Over 1100 Days Since MCIT, Still No TCET In Sight
AdvaMed’s new online clock documents the time since CMS promised to replace MCIT, a program guaranteeing coverage for FDA-cleared breakthrough devices.
NAM’S Health Care AI Development Code Of Conduct Addresses Gaps In Current Principles
The National Academy of Medicine developed a code of conduct for health care AI development, as well as commitments for code implementation.